Omalizumab Overview Categories 25 Drugs acting on the respiratory tract25.1 Anti-asthmatic drugs25.1.1 Oral/Parenteral antiasthmatics Page headings Overview Primary Characterstics Indications Pharmacokinetics Contraindications Drug Interactions Side Effects Dosage High Risk Groups Warning / Precautions Storage Conditions Interference in Pathology Brands of Omalizumab Manufacturers of Omalizumab Primary Characterstics Indications Back to top Pharmacokinetics Back to top Contraindications Back to top Drug Interactions Back to top Side Effects Back to top Dosage Omalizumab's dosage details are as follows: Dose Single Dose Frequency Route Instructions Adult Dosage 75 to 375 mg220 (225)As recommended.SCShould be given for 2 to 4 weeks, with dosing frequency determined by serum IgE level and weight. Paedriatic Dosage (20kg) No data regarding the Paedriatic dosage details of Omalizumab is available. Neonatal Dosage (3kg) No data regarding the neonatal dosage details of Omalizumab is available. High Risk Groups Back to top Warning / Precautions Back to top Storage Conditions Back to top Interference in Pathology Back to top Brands / Trade Names of Omalizumab Back to top Manufacturers of Omalizumab in Pakistan Novartis Back to top Previous Drug Generic - Next Drug Generic
Omalizumab Overview Categories 25 Drugs acting on the respiratory tract25.1 Anti-asthmatic drugs25.1.1 Oral/Parenteral antiasthmatics Page headings Overview Primary Characterstics Indications Pharmacokinetics Contraindications Drug Interactions Side Effects Dosage High Risk Groups Warning / Precautions Storage Conditions Interference in Pathology Brands of Omalizumab Manufacturers of Omalizumab Primary Characterstics Indications Back to top Pharmacokinetics Back to top Contraindications Back to top Drug Interactions Back to top Side Effects Back to top Dosage Omalizumab's dosage details are as follows: Dose Single Dose Frequency Route Instructions Adult Dosage 75 to 375 mg220 (225)As recommended.SCShould be given for 2 to 4 weeks, with dosing frequency determined by serum IgE level and weight. Paedriatic Dosage (20kg) No data regarding the Paedriatic dosage details of Omalizumab is available. Neonatal Dosage (3kg) No data regarding the neonatal dosage details of Omalizumab is available. High Risk Groups Back to top Warning / Precautions Back to top Storage Conditions Back to top Interference in Pathology Back to top Brands / Trade Names of Omalizumab Back to top Manufacturers of Omalizumab in Pakistan Novartis Back to top Previous Drug Generic - Next Drug Generic